Detalhe da pesquisa
1.
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Ann Hematol
; 103(4): 1221-1233, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413410
2.
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152053
3.
Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
Haematologica
; 107(1): 178-186, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375775
4.
The insertion site is the main risk factor for central venous catheter-related complications in patients with hematologic malignancies.
Am J Hematol
; 97(3): 303-310, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978721
5.
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Ann Hematol
; 100(6): 1463-1471, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903952
6.
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
Pediatr Blood Cancer
; 66(11): e27948, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347788
7.
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Eur J Haematol
; 100(2): 154-162, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114972
8.
High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
Ann Hematol
; 92(4): 443-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23250622
9.
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.
Genes Chromosomes Cancer
; 51(8): 756-67, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488577
10.
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.
Exp Hematol
; 107: 38-50, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952140
11.
Prediction of Adult Height by Machine Learning Technique.
J Clin Endocrinol Metab
; 106(7): e2700-e2710, 2021 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606028
12.
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events.
Leuk Lymphoma
; 61(13): 3066-3077, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723198
13.
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy]. / Sehr schweres Differenzierungssyndrom bei Niedrigrisiko akuter Promyelozytenleukämie eine Tücke der differenzierenden Therapie.
Dtsch Med Wochenschr
; 142(2): 111-114, 2017 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-28114716
14.
Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
Clin Lymphoma Myeloma Leuk
; 17(12): 889-896.e5, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923666
15.
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia.
Leuk Res
; 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26344466
16.
Prognostic importance of expression of the Wilms' tumor 1 gene in newly diagnosed acute promyelocytic leukemia.
Leuk Lymphoma
; 56(8): 2289-95, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426668
17.
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.
Leukemia
; 34(2): 662-666, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511612
18.
In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.
Leuk Res
; 37(4): 378-82, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23287429
19.
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS]. / Kryptokokkenmeningoenzephalitis bei einem HIV-positiven Patienten mit Rezidiv bei Resistenz gegenüber Fluconazol und IRIS.
Med Klin (Munich)
; 104(1): 58-62, 2009 Jan 15.
Artigo
em Alemão
| MEDLINE | ID: mdl-19142596